Skip to search formSkip to main contentSkip to account menu

contralateral breast cancer

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background: LCIS is considered a risk factor for bilateral breast cancer, but the effect of LCIS diagnosed concurrently with DCIS… 
2016
2016
Node negative microscopically invasive breast cancer (BC) is frequently associated with ductal carcinoma in situ (DCIS) and… 
Review
2013
Review
2013
Background The optimal local management of early-stage breast cancer in BRCA-mutation carriers remains a matter of debate. These… 
2012
2012
Background: It is not clear if bisphosphonates (BP) are associated with improved breast cancer prognosis in women with early… 
2011
2011
Background: The intent of contralateral prophylactic mastectomy (CPM) is to improve survival after a diagnosis of unilateral… 
2010
2010
538 Background: The scatter dose to the opposite breast during adjuvant radiotherapy is approximately 2-3 Gy. Several studies… 
2010
2010
Purpose: Bilateral breast cancer is an uncommon clinical entity. There is no specific treatment strategy and controversial issues… 
2009
2009
Context—The risk of breast cancer in BRCA1 and BRCA2 mutation carriers has been examined in many studies, but relatively little… 
2008
2008
586 Background: Bilateral breast cancer (BBC) has a cumulative incidence of 7- 20%. Earlier studies suggested that… 
Review
2002
Review
2002
Abstract : Women with breast cancer arising as a consequence of germline mutations in BRCA1 or BRCA2 are at significant risk of…